INJIZIERBARE ZUBEREITUNG

European patent · EP3746047 · In force

Register entry

Publication number
EP3746047
Application number
EP19733972
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 12, 2019
Published
Dec 9, 2020
Granted
Oct 13, 2021
Protection ends at the latest
Jun 11, 2039
Next annual fee due
Jun 30, 2027
IPC classes
A61K 9/00 (2006.01)
A61K 31/4196 (2006.01)
A61K 47/34 (2017.01)
Priority
EP 18382413 12.06.2018
PCT application
PCT/EP2019/065318 12.06.2019
PCT publication
WO2019/238740 19.12.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Aug 24, 2022

    Change

    Published in Swissreg on 24.08.2022

  6. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  7. Oct 13, 2021

    Granted

    Published in Swissreg on 13.10.2021

Parties

Holder

LABORATORIOS FARMACEUTICOS ROVI, S.A.

Laboratorios Farmacéuticos Rovi, S.A.

C/ Julián Camarillo 35, 28037 Madrid, ES

Inventor

FRANCO RODRÍGUEZ, Guillermo

28037 Madrid, ES

GUTIERRO ADURIZ, Ibon

28037 Madrid, ES

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.